c-MET inhibitor LY2801653, Purity ≥98%

Cat. No.: X24-06-ZQ214

c-MET inhibitor LY2801653, Purity ≥98%

Synonym: 1206799-15-6; c-MET inhibitor; LY-2801653; Merestinib

  • CAS Number: 1206799-15-6
  • Compound CID: 44603533
Product Size
5 mg; 10 mg; 50 mg
Price
Datasheet
MSDS
Properties
Description
LY2801653, soluble in DMSO and ethanol and insoluble in water, inhibits the enzymatic activity of the c-Met tyrosine kinase, the receptor of hepatocyte growth factor/scatter factor (HGF/SF), interfering with pathways leading to cell growth and metastasis. It targets MET.
Molecular Weight
552.53
Molecular Formula
C30H22F2N6O3
Targets
MET: 2 nM (Ki)
Form
Lyophilized powder
Purity
≥98%
Solubility
DMSO: 88 mg/mL (159.26 mM); Water: Insoluble; Ethanol: 88 mg/mL
Identity
Confirmed by NMR/HPLC/MS.
Applications
LY2801653 inhibits c-MET, allowing researchers to study its effects on cancer progression and metastasis.
Related Products

Christmas 2024

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.
0